Skip to content

Clinical trials

Hepatitis C trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: United States Clear all

720 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20007
20019
200215
200314
200419
200529
200625
200726
200835
200940
201047
201162
201247
201342
201448
201547
201626
201737
201828
201927
202015
202111
202213
202310
20246
20255
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed552
Terminated75
Withdrawn31
Unknown status24
Recruiting19
Active, not recruiting9
Not yet recruiting6
Suspended2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences73
Bristol-Myers Squibb47
National Institute of Allergy and Infectious Diseases (NIAID)35
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)21
Vertex Pharmaceuticals Incorporated16
GlaxoSmithKline13
AbbVie12
Icahn School of Medicine at Mount Sinai12
Johns Hopkins University12
Massachusetts General Hospital12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C720
Hepatitis C, Chronic109
HIV Infections62
Acquired Immunodeficiency Syndrome50
Fibrosis50
Liver Diseases48
Hepatitis43
Hepatitis B31
Substance-Related Disorders25
Carcinoma, Hepatocellular24

Trials

Showing 26 to 50 of 720. Each trial links to its page on Pharma Observatory.

620 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.